… that male and female breast cancer differ in their molecular landscapes. In this systematic
review, we consolidated all existing prognostic biomarker data in male breast cancer spanning …

… genes are the most well-known genetic abnormalities linked to this malignancy [39]. Situated
on chromosome 17, the BRCA1 gene … cases of breast cancer, the ERBB2 gene is amplified, …

… underlying gene copy number alterations and we evaluated … Chromosome 17 copy numbers
that are detected by FISH can … in breast cancer patients, even without concurrent ERBB2 …

… SPEC ERBB2 probe specific for the chromosomal region … We evaluated the HER2/neu gene
amplification status by D-… the discrepancy in evaluating chromosome 17 abnormalities in our …

… of BC, we evaluated the efficacy of attMIL pipelines in predicting ERα and PR status in both
… which could be predictive of the hormone receptor status of the tumor in H&E-stained slides. …

… ERBB2 FISH and heterogeneity assessment. Central pathology evaluation of HER2 status
was … to chromosome 17 centromeric probe [CEP17] ≥ 2 or ERBB2 copy number ≥ 6). HER2 …

… classification and contribute to new biomarker assessment … By developing a refined
ddPCR assay for ERBB2 mRNA … in altered gene expression patterns, splicing anomalies, and …

… gene, located on chromosome 17, is a suppressor gene that … of developing breast cancer
regardless of menopausal status. … These mutations, including NF1 loss and ERBB2 activating …

… alone (eg, chromosome 17 ERBB2 gene locus), resulting in … most common abnormalities
in GEA and breast cancers, none … the value of CMA in GEA evaluation. Our study calls for the …

… directly against molecular abnormalities or tumor cells that cause cancer development. The
… the tyrosine kinase of HER1, HER2 / ErbB2, and EGFR, subsequently prevents the receptor …